Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
=====[[Dipeptidyl peptidase IV]] Inhibitor===== | =====[[Dipeptidyl peptidase IV]] Inhibitor===== | ||
* [[Galvus]] - Generic: [[Vildagliptin]] | * [[Galvus]] - Generic: [[Vildagliptin]] | ||
| - | * [[Januvia]] - Generic: [[Sitagliptin]] [[Januvia (sitagliptin)]] | + | * [[Januvia]] - Generic: [[Sitagliptin]]; see also [[Januvia (sitagliptin)]] |
* [[Onglyza]] - Generic: [[Saxagliptin]] | * [[Onglyza]] - Generic: [[Saxagliptin]] | ||
=====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | =====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | ||
Revision as of 14:04, 9 January 2024
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
